Acorda Therapeutics Inc EV/EBIT
What is the EV/EBIT of Acorda Therapeutics Inc?
The EV/EBIT of Acorda Therapeutics Inc is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Acorda Therapeutics Inc
What does Acorda Therapeutics Inc do?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Companies with ev/ebit similar to Acorda Therapeutics Inc
- Sunniva has EV/EBIT of N/A
- HighPoint Resources Corp has EV/EBIT of N/A
- Deccan Gold Mines has EV/EBIT of N/A
- KWESST Micro Systems has EV/EBIT of N/A
- Hepion Pharmaceuticals Inc has EV/EBIT of N/A
- Check-Cap Ltd has EV/EBIT of N/A
- Acorda Therapeutics Inc has EV/EBIT of N/A
- 21 St Century Manag has EV/EBIT of N/A
- Cornerstone FS Plc has EV/EBIT of N/A
- Asensus Surgical Inc has EV/EBIT of N/A
- Aurelius Minerals has EV/EBIT of N/A
- Pintec Technology Ltd has EV/EBIT of N/A
- Spherix has EV/EBIT of N/A